Source: Eur Respir J 2004; 23: 832-840
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O'Donnell D.E., Fluge T., Gerken F., Hamilton A., Webb K., Aguilaniu B., Make B., Magnussen H.. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832-840

Member's Comments

No comment yet.

Related content which might interest you: Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 86-94 Year: 2004 Exercise and dyspnoea in COPD Source: Eur Respir Rev 2006; 15: 72-79 Year: 2006 Lung hyperinflation in COPD: the impact of pharmacotherapy Source: Eur Respir Rev 2006; 15: 85-89 Year: 2006 Heliox, dyspnoea and exercise in COPD Source: Eur Respir Rev 2009; 19: 30-38 Year: 2010 Dyspnoea Source: Respipedia Article Year: 2016 Lung hyperinflation, dyspnoe, and exercise tolerance in patients with COPD exacerbation Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD Source: Eur Respir J 2004; 24: 385-390 Year: 2004 Physiology and consequences of lung hyperinflation in COPD Source: Eur Respir Rev 2006; 15: 61-67 Year: 2006 Tiotropium as essential maintenance therapy in COPD Source: Eur Respir Rev 2006; 15: 51-57 Year: 2006 Evaluation of bronchodilator responses in patients with "irreversible" emphysema Source: Eur Respir J 2001; 18: 914-920 Year: 2001 A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 19: 217-224 Year: 2002 Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 19: 639-644 Year: 2002 Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Mechanisms limiting exercise in COPD: new insights Source: Annual Congress 2005 - Mechanical factors limiting physical exercise in disease Year: 2005 NIV and pulmonary rehabilitation Source: Eur Respir Mon; 2008: 41: 265–271 Year: 2008 Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance Source: Eur Respir Rev 2006; 15: 37-41 Year: 2006 Bronchodilator responsiveness in patients with COPD Source: Eur Respir J 2008; 31: 742-750 Year: 2008 New strategies to improve exercise capacity in COPD Source: Annual Congress 2006 - MP1 – New strategies to improve exercise capacity in COPD Year: 2006 Enhanced cytokine response to exercise in COPD Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006 Impact of exercise training on quality of life in patients with end-stage emphysema Source: Annual Congress 2006 - Contemporary management of patients with end-stage emphysema Year: 2006